FDA advisory committee recommends JNJ's booster shot
The S&P 500 is trading near session highs with a 0.7% gain while the Russell 2000 trades higher by 0.6%. Earlier, the FDA Vaccines and Related Biological Products Advisory Committee unanimously recommended Johnson & Johnson's (JNJ 161.02, +0.91, +0.6%) booster shot for people 18 and older. JNJ shares are up modestly. Separately, Reuters recently reported that Senators Klobuchar (D-MN) and Grassley (R-IA) will soon introduce a bill that will limit the ability of large technology companies to favor their own products and services.